Your browser doesn't support javascript.
loading
Antibody Feedback Limits the Expansion of B Cell Responses to Malaria Vaccination but Drives Diversification of the Humoral Response.
McNamara, Hayley A; Idris, Azza H; Sutton, Henry J; Vistein, Rachel; Flynn, Barbara J; Cai, Yeping; Wiehe, Kevin; Lyke, Kirsten E; Chatterjee, Deepyan; Kc, Natasha; Chakravarty, Sumana; Lee Sim, B Kim; Hoffman, Stephen L; Bonsignori, Mattia; Seder, Robert A; Cockburn, Ian A.
Afiliação
  • McNamara HA; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, the Australian National University, Canberra, ACT 2601, Australia.
  • Idris AH; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Sutton HJ; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, the Australian National University, Canberra, ACT 2601, Australia.
  • Vistein R; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Flynn BJ; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Cai Y; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, the Australian National University, Canberra, ACT 2601, Australia.
  • Wiehe K; Duke Human Vaccine Institute, Durham, NC 27710, USA; Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
  • Lyke KE; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
  • Chatterjee D; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, the Australian National University, Canberra, ACT 2601, Australia.
  • Kc N; Sanaria Inc., Rockville, MD 20850, USA.
  • Chakravarty S; Sanaria Inc., Rockville, MD 20850, USA.
  • Lee Sim BK; Sanaria Inc., Rockville, MD 20850, USA.
  • Hoffman SL; Sanaria Inc., Rockville, MD 20850, USA.
  • Bonsignori M; Duke Human Vaccine Institute, Durham, NC 27710, USA; Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
  • Seder RA; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Cockburn IA; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, the Australian National University, Canberra, ACT 2601, Australia. Electronic address: ian.cockburn@anu.edu.au.
Cell Host Microbe ; 28(4): 572-585.e7, 2020 10 07.
Article em En | MEDLINE | ID: mdl-32697938
ABSTRACT
Generating sufficient antibody to block infection is a key challenge for vaccines against malaria. Here, we show that antibody titers to a key target, the repeat region of the Plasmodium falciparum circumsporozoite protein (PfCSP), plateaued after two immunizations in a clinical trial of the radiation-attenuated sporozoite vaccine. To understand the mechanisms limiting vaccine responsiveness, we developed immunoglobulin (Ig)-knockin mice with elevated numbers of PfCSP-binding B cells. We determined that recall responses were inhibited by antibody feedback, potentially via epitope masking of the immunodominant PfCSP repeat region. Importantly, the amount of antibody that prevents boosting is below the amount of antibody required for protection. Finally, while antibody feedback limited responses to the PfCSP repeat region in vaccinated volunteers, potentially protective subdominant responses to PfCSP C-terminal regions expanded with subsequent boosts. These data suggest that antibody feedback drives the diversification of immune responses and that vaccination for malaria will require targeting multiple antigens.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Antiprotozoários / Linfócitos B / Vacinação / Vacinas Antimaláricas Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Antiprotozoários / Linfócitos B / Vacinação / Vacinas Antimaláricas Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article